Index by author

01 September 2004; volume 24, issue 3

A

  1. Aksoy, M.O.

    1. Yang, Y. et al "Regulation of interleukin-1β and interleukin-1β inhibitor release by human airway epithelial cells." European Respiratory Journal 24.3 (2004): 360-366. Web. 13 June. 2021.

  2. Alonso, A.

    1. García-Río, F. et al "Spirometric reference equations for European females and males aged 65–85 yrs." European Respiratory Journal 24.3 (2004): 397-405. Web. 13 June. 2021.

  3. Arends, L.R.

    1. Visser, M.J. et al "Side-effects of fluticasone in asthmatic children: no effects after dose reduction." European Respiratory Journal 24.3 (2004): 420-425. Web. 13 June. 2021.

  4. Armstrong, D.

    1. Griffiths, A.L. et al "Cystic fibrosis patients and families support cross-infection measures." European Respiratory Journal 24.3 (2004): 449-452. Web. 13 June. 2021.

  5. Arnold, J.L.

    1. Arnold, J.L.. "ERJ at your fingertips." European Respiratory Journal 24.3 (2004): 335-336. Web. 13 June. 2021.

B

  1. Banatvala, N.

    1. de Colombani, P. et al "European framework to decrease the burden of TB/HIV." European Respiratory Journal 24.3 (2004): 493-501. Web. 13 June. 2021.

  2. Barker, P.M.

    1. Barker, P.M. et al "Primary pulmonary lymphangiectasia in infancy and childhood." European Respiratory Journal 24.3 (2004): 413-419. Web. 13 June. 2021.

  3. Barnes, N.C.

    1. Elston, W.J. et al "Safety of research bronchoscopy, biopsy and bronchoalveolar lavage in asthma." European Respiratory Journal 24.3 (2004): 375-377. Web. 13 June. 2021.

  4. Barst, R.J.

    1. Humbert, M. et al "Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2." European Respiratory Journal 24.3 (2004): 353-359. Web. 13 June. 2021.
    2. Roberts, K.E. et al "BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease." European Respiratory Journal 24.3 (2004): 371-374. Web. 13 June. 2021.

  5. Beasley, R.

    1. Masoli, M. et al " From the authors: ." European Respiratory Journal 24.3 (2004): 513-514. Web. 13 June. 2021.

  6. Beers, M.F.

    1. Brasch, F. et al "Surfactant proteins in pulmonary alveolar proteinosis in adults." European Respiratory Journal 24.3 (2004): 426-435. Web. 13 June. 2021.

  7. Bergdahl, I.

    1. Bergdahl, I. et al " From the authors: ." European Respiratory Journal 24.3 (2004): 512. Web. 13 June. 2021.

  8. Bernstein, D.M.

    1. Bernstein, D.M.. "Increased mortality in COPD among construction workers exposed to inorganic dust." European Respiratory Journal 24.3 (2004): 512. Web. 13 June. 2021.

  9. Bianchi, R.

    1. Romagnoli, I. et al "Chest wall kinematics and respiratory muscle action in ankylosing spondylitis patients." European Respiratory Journal 24.3 (2004): 453-460. Web. 13 June. 2021.

  10. Bin, W.

    1. Yang, Y. et al "Regulation of interleukin-1β and interleukin-1β inhibitor release by human airway epithelial cells." European Respiratory Journal 24.3 (2004): 360-366. Web. 13 June. 2021.

  11. Birzele, J.

    1. Brasch, F. et al "Surfactant proteins in pulmonary alveolar proteinosis in adults." European Respiratory Journal 24.3 (2004): 426-435. Web. 13 June. 2021.

  12. Björkstén, B.

    1. Weiland, S.K. et al "Phase II of the International Study of Asthma and Allergies in Childhood (ISAAC II): rationale and methods." European Respiratory Journal 24.3 (2004): 406-412. Web. 13 June. 2021.

  13. Boehler, A.

    1. Brasch, F. et al "Surfactant proteins in pulmonary alveolar proteinosis in adults." European Respiratory Journal 24.3 (2004): 426-435. Web. 13 June. 2021.

  14. Boonstra, A.

    1. Humbert, M. et al "Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2." European Respiratory Journal 24.3 (2004): 353-359. Web. 13 June. 2021.

  15. Botebol-Benhamou, G.

    1. Quintana-Gallego, E. et al "Home respiratory polygraphy for diagnosis of sleep-disordered breathing in heart failure." European Respiratory Journal 24.3 (2004): 443-448. Web. 13 June. 2021.

  16. Bouros, D.E.

    1. Liapakis, I.E. et al "Penetration of newer quinolones in the empyema fluid." European Respiratory Journal 24.3 (2004): 466-470. Web. 13 June. 2021.

  17. Brambilla, C.

    1. Lantuejoul, S. et al "Adenocarcinoma of the lung mimicking inflammatory lung disease with honeycombing." European Respiratory Journal 24.3 (2004): 502-505. Web. 13 June. 2021.

  18. Brambilla, E.

    1. Lantuejoul, S. et al "Adenocarcinoma of the lung mimicking inflammatory lung disease with honeycombing." European Respiratory Journal 24.3 (2004): 502-505. Web. 13 June. 2021.

  19. Brand, P.L.P.

    1. Visser, M.J. et al "Side-effects of fluticasone in asthmatic children: no effects after dose reduction." European Respiratory Journal 24.3 (2004): 420-425. Web. 13 June. 2021.

  20. Brasch, F.

    1. Brasch, F. et al "Surfactant proteins in pulmonary alveolar proteinosis in adults." European Respiratory Journal 24.3 (2004): 426-435. Web. 13 June. 2021.

  21. Brichon, P.Y.

    1. Lantuejoul, S. et al "Adenocarcinoma of the lung mimicking inflammatory lung disease with honeycombing." European Respiratory Journal 24.3 (2004): 502-505. Web. 13 June. 2021.

  22. Brunekreef, B.

    1. Weiland, S.K. et al "Phase II of the International Study of Asthma and Allergies in Childhood (ISAAC II): rationale and methods." European Respiratory Journal 24.3 (2004): 406-412. Web. 13 June. 2021.

C

  1. Cammelli, D.

    1. Romagnoli, I. et al "Chest wall kinematics and respiratory muscle action in ankylosing spondylitis patients." European Respiratory Journal 24.3 (2004): 453-460. Web. 13 June. 2021.

  2. Capote, F.

    1. Quintana-Gallego, E. et al "Home respiratory polygraphy for diagnosis of sleep-disordered breathing in heart failure." European Respiratory Journal 24.3 (2004): 443-448. Web. 13 June. 2021.

  3. Carlsson, L.-G.

    1. Ingelf, J., J. Ekelund, and L.-G. Carlsson. "Meta-analysis on dose-response relationship of inhaled steroids must be done in homogenous asthma populations." European Respiratory Journal 24.3 (2004): 513. Web. 13 June. 2021.

  4. Carmona-Bernal, C.

    1. Quintana-Gallego, E. et al "Home respiratory polygraphy for diagnosis of sleep-disordered breathing in heart failure." European Respiratory Journal 24.3 (2004): 443-448. Web. 13 June. 2021.

  5. Carzino, R.

    1. Griffiths, A.L. et al "Cystic fibrosis patients and families support cross-infection measures." European Respiratory Journal 24.3 (2004): 449-452. Web. 13 June. 2021.

  6. Channick, R.N.

    1. Humbert, M. et al "Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2." European Respiratory Journal 24.3 (2004): 353-359. Web. 13 June. 2021.

  7. Colby, T.V.

    1. Lantuejoul, S. et al "Adenocarcinoma of the lung mimicking inflammatory lung disease with honeycombing." European Respiratory Journal 24.3 (2004): 502-505. Web. 13 June. 2021.

  8. Cookson, W.O.C.

    1. Weiland, S.K. et al "Phase II of the International Study of Asthma and Allergies in Childhood (ISAAC II): rationale and methods." European Respiratory Journal 24.3 (2004): 406-412. Web. 13 June. 2021.

  9. Crapo, R.O.

    1. Crapo, R.O.. "The role of reference values in interpreting lung function tests." European Respiratory Journal 24.3 (2004): 341-342. Web. 13 June. 2021.

D

  1. Daniil, Z.

    1. Kapotsis, G.E. et al "A young male with chest pain, cough and fever." European Respiratory Journal 24.3 (2004): 506-509. Web. 13 June. 2021.

  2. de Colombani, P.

    1. de Colombani, P. et al "European framework to decrease the burden of TB/HIV." European Respiratory Journal 24.3 (2004): 493-501. Web. 13 June. 2021.

  3. Delgado, J.M.

    1. Escobar-Sacristán, J.A. et al "Endobronchial brachytherapy in the treatment of malignant lung tumours." European Respiratory Journal 24.3 (2004): 348-352. Web. 13 June. 2021.

  4. de Vries, T.W.

    1. Visser, M.J. et al "Side-effects of fluticasone in asthmatic children: no effects after dose reduction." European Respiratory Journal 24.3 (2004): 420-425. Web. 13 June. 2021.

  5. Dimitroulis, I.

    1. Kosmas, E.N. et al "Exercise-induced flow limitation, dynamic hyperinflation and exercise capacity in patients with bronchial asthma." European Respiratory Journal 24.3 (2004): 378-384. Web. 13 June. 2021.

  6. Dinh-Xuan, A.T.

    1. Hoeper, M.M., and A.T. Dinh-Xuan. "Combination therapy for pulmonary arterial hypertension: still more questions than answers." European Respiratory Journal 24.3 (2004): 339-340. Web. 13 June. 2021.

  7. Dorgham, A.

    1. García-Río, F. et al "Spirometric reference equations for European females and males aged 65–85 yrs." European Respiratory Journal 24.3 (2004): 397-405. Web. 13 June. 2021.

  8. Douglas, N.J.

    1. Wild, M.R. et al "Can psychological factors help us to determine adherence to CPAP? A prospective study." European Respiratory Journal 24.3 (2004): 461-465. Web. 13 June. 2021.

  9. Duiverman, E.J.

    1. Visser, M.J. et al "Side-effects of fluticasone in asthmatic children: no effects after dose reduction." European Respiratory Journal 24.3 (2004): 420-425. Web. 13 June. 2021.

E

  1. Earnest, A.

    1. Ong, K-C. et al "Pulmonary function and exercise capacity in survivors of severe acute respiratory syndrome." European Respiratory Journal 24.3 (2004): 436-442. Web. 13 June. 2021.

  2. Ekelund, J.

    1. Ingelf, J., J. Ekelund, and L.-G. Carlsson. "Meta-analysis on dose-response relationship of inhaled steroids must be done in homogenous asthma populations." European Respiratory Journal 24.3 (2004): 513. Web. 13 June. 2021.

  3. Elston, W.J.

    1. Elston, W.J. et al "Safety of research bronchoscopy, biopsy and bronchoalveolar lavage in asthma." European Respiratory Journal 24.3 (2004): 375-377. Web. 13 June. 2021.

  4. Eng, P.

    1. Low, S-Y., A. Hsu, and P. Eng. "Interventional bronchoscopy for tuberculous tracheobronchial stenosis." European Respiratory Journal 24.3 (2004): 345-347. Web. 13 June. 2021.

  5. Engleman, H.M.

    1. Wild, M.R. et al "Can psychological factors help us to determine adherence to CPAP? A prospective study." European Respiratory Journal 24.3 (2004): 461-465. Web. 13 June. 2021.

  6. Eriksson, K.

    1. Bergdahl, I. et al " From the authors: ." European Respiratory Journal 24.3 (2004): 512. Web. 13 June. 2021.

  7. Escobar-Sacristán, J.A.

    1. Escobar-Sacristán, J.A. et al "Endobronchial brachytherapy in the treatment of malignant lung tumours." European Respiratory Journal 24.3 (2004): 348-352. Web. 13 June. 2021.

  8. Espie, C.A.

    1. Wild, M.R. et al "Can psychological factors help us to determine adherence to CPAP? A prospective study." European Respiratory Journal 24.3 (2004): 461-465. Web. 13 June. 2021.

  9. Esther, C.R.

    1. Barker, P.M. et al "Primary pulmonary lymphangiectasia in infancy and childhood." European Respiratory Journal 24.3 (2004): 413-419. Web. 13 June. 2021.

  10. Ewig, S.

    1. Khanavkar, B., and S. Ewig. "A new tool for an old disease." European Respiratory Journal 24.3 (2004): 343-344. Web. 13 June. 2021.

F

  1. Ferretti, G.R.

    1. Lantuejoul, S. et al "Adenocarcinoma of the lung mimicking inflammatory lung disease with honeycombing." European Respiratory Journal 24.3 (2004): 502-505. Web. 13 June. 2021.

  2. Flodin, R.

    1. Bergdahl, I. et al " From the authors: ." European Respiratory Journal 24.3 (2004): 512. Web. 13 June. 2021.

  3. Flood-Page, P.

    1. Elston, W.J. et al "Safety of research bronchoscopy, biopsy and bronchoalveolar lavage in asthma." European Respiratory Journal 24.3 (2004): 375-377. Web. 13 June. 2021.

  4. Fordham, L.A.

    1. Barker, P.M. et al "Primary pulmonary lymphangiectasia in infancy and childhood." European Respiratory Journal 24.3 (2004): 413-419. Web. 13 June. 2021.

  5. Funkhouser, W.K.

    1. Barker, P.M. et al "Primary pulmonary lymphangiectasia in infancy and childhood." European Respiratory Journal 24.3 (2004): 413-419. Web. 13 June. 2021.

G

  1. Gaga, M.

    1. Kosmas, E.N. et al "Exercise-induced flow limitation, dynamic hyperinflation and exercise capacity in patients with bronchial asthma." European Respiratory Journal 24.3 (2004): 378-384. Web. 13 June. 2021.

  2. Galarducci, A.

    1. Romagnoli, I. et al "Chest wall kinematics and respiratory muscle action in ankylosing spondylitis patients." European Respiratory Journal 24.3 (2004): 453-460. Web. 13 June. 2021.

  3. Galiè, N.

    1. Humbert, M. et al "Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2." European Respiratory Journal 24.3 (2004): 353-359. Web. 13 June. 2021.

  4. García-Río, F.

    1. García-Río, F. et al "Spirometric reference equations for European females and males aged 65–85 yrs." European Respiratory Journal 24.3 (2004): 397-405. Web. 13 June. 2021.

  5. Georgiadou, O.

    1. Vogiatzis, I. et al "Dynamic hyperinflation and tolerance to interval exercise in patients with advanced COPD." European Respiratory Journal 24.3 (2004): 385-390. Web. 13 June. 2021.

  6. Gigliotti, F.

    1. Romagnoli, I. et al "Chest wall kinematics and respiratory muscle action in ankylosing spondylitis patients." European Respiratory Journal 24.3 (2004): 453-460. Web. 13 June. 2021.

  7. Granda-Orive, J.I.

    1. Escobar-Sacristán, J.A. et al "Endobronchial brachytherapy in the treatment of malignant lung tumours." European Respiratory Journal 24.3 (2004): 348-352. Web. 13 June. 2021.

  8. Griffiths, A.L.

    1. Griffiths, A.L. et al "Cystic fibrosis patients and families support cross-infection measures." European Respiratory Journal 24.3 (2004): 449-452. Web. 13 June. 2021.

  9. Gutiérrez Jiménez, T.

    1. Escobar-Sacristán, J.A. et al "Endobronchial brachytherapy in the treatment of malignant lung tumours." European Respiratory Journal 24.3 (2004): 348-352. Web. 13 June. 2021.

  10. Guttentag, S.H.

    1. Brasch, F. et al "Surfactant proteins in pulmonary alveolar proteinosis in adults." European Respiratory Journal 24.3 (2004): 426-435. Web. 13 June. 2021.

H

  1. Hallstrand, T.S.

    1. Hallstrand, T.S. et al "Inhaled IFN-γ for persistent nontuberculous mycobacterial pulmonary disease due to functional IFN-γ deficiency." European Respiratory Journal 24.3 (2004): 367-370. Web. 13 June. 2021.

  2. Hart, N.

    1. Hart, N., J. Moxham, and M.I. Polkey. " From the authors: ." European Respiratory Journal 24.3 (2004): 511. Web. 13 June. 2021.

  3. Hawgood, S.

    1. Brasch, F. et al "Surfactant proteins in pulmonary alveolar proteinosis in adults." European Respiratory Journal 24.3 (2004): 426-435. Web. 13 June. 2021.

  4. Hedlund, U.

    1. Bergdahl, I. et al " From the authors: ." European Respiratory Journal 24.3 (2004): 512. Web. 13 June. 2021.

  5. Hoeper, M.M.

    1. Hoeper, M.M., and A.T. Dinh-Xuan. "Combination therapy for pulmonary arterial hypertension: still more questions than answers." European Respiratory Journal 24.3 (2004): 339-340. Web. 13 June. 2021.

  6. Holt, S.

    1. Masoli, M. et al " From the authors: ." European Respiratory Journal 24.3 (2004): 513-514. Web. 13 June. 2021.

  7. Horn, E.M.

    1. Humbert, M. et al "Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2." European Respiratory Journal 24.3 (2004): 353-359. Web. 13 June. 2021.

  8. Hsu, A.

    1. Low, S-Y., A. Hsu, and P. Eng. "Interventional bronchoscopy for tuberculous tracheobronchial stenosis." European Respiratory Journal 24.3 (2004): 345-347. Web. 13 June. 2021.

  9. Humbert, M.

    1. Humbert, M. et al "Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2." European Respiratory Journal 24.3 (2004): 353-359. Web. 13 June. 2021.

I

  1. Ingelf, J.

    1. Ingelf, J., J. Ekelund, and L.-G. Carlsson. "Meta-analysis on dose-response relationship of inhaled steroids must be done in homogenous asthma populations." European Respiratory Journal 24.3 (2004): 513. Web. 13 June. 2021.

J

  1. Järvholm, B.

    1. Bergdahl, I. et al " From the authors: ." European Respiratory Journal 24.3 (2004): 512. Web. 13 June. 2021.

  2. Jeffery, P.K.

    1. Elston, W.J. et al "Safety of research bronchoscopy, biopsy and bronchoalveolar lavage in asthma." European Respiratory Journal 24.3 (2004): 375-377. Web. 13 June. 2021.

  3. Johnen, G.

    1. Brasch, F. et al "Surfactant proteins in pulmonary alveolar proteinosis in adults." European Respiratory Journal 24.3 (2004): 426-435. Web. 13 June. 2021.

K

  1. Kalomenidis, I.

    1. Kapotsis, G.E. et al "A young male with chest pain, cough and fever." European Respiratory Journal 24.3 (2004): 506-509. Web. 13 June. 2021.

  2. Kapotsis, G.E.

    1. Kapotsis, G.E. et al "A young male with chest pain, cough and fever." European Respiratory Journal 24.3 (2004): 506-509. Web. 13 June. 2021.

  3. Kastanakis, E.

    1. Vogiatzis, I. et al "Dynamic hyperinflation and tolerance to interval exercise in patients with advanced COPD." European Respiratory Journal 24.3 (2004): 385-390. Web. 13 June. 2021.

  4. Kauffmann, F.

    1. Kauffmann, F., and . "Post-genome respiratory epidemiology: a multidisciplinary challenge." European Respiratory Journal 24.3 (2004): 471-480. Web. 13 June. 2021.

  5. Kaw, G.

    1. Ong, K-C. et al "Pulmonary function and exercise capacity in survivors of severe acute respiratory syndrome." European Respiratory Journal 24.3 (2004): 436-442. Web. 13 June. 2021.

  6. Kelsen, S.G.

    1. Yang, Y. et al "Regulation of interleukin-1β and interleukin-1β inhibitor release by human airway epithelial cells." European Respiratory Journal 24.3 (2004): 360-366. Web. 13 June. 2021.

  7. Khan, L.N.

    1. Elston, W.J. et al "Safety of research bronchoscopy, biopsy and bronchoalveolar lavage in asthma." European Respiratory Journal 24.3 (2004): 375-377. Web. 13 June. 2021.

  8. Khanavkar, B.

    1. Khanavkar, B., and S. Ewig. "A new tool for an old disease." European Respiratory Journal 24.3 (2004): 343-344. Web. 13 June. 2021.

  9. Knowles, J.A.

    1. Roberts, K.E. et al "BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease." European Respiratory Journal 24.3 (2004): 371-374. Web. 13 June. 2021.

  10. Kosmas, E.N.

    1. Kosmas, E.N. et al "Exercise-induced flow limitation, dynamic hyperinflation and exercise capacity in patients with bronchial asthma." European Respiratory Journal 24.3 (2004): 378-384. Web. 13 June. 2021.

  11. Kottakis, I.

    1. Liapakis, I.E. et al "Penetration of newer quinolones in the empyema fluid." European Respiratory Journal 24.3 (2004): 466-470. Web. 13 June. 2021.

  12. Koulouris, N.G.

    1. Kosmas, E.N. et al "Exercise-induced flow limitation, dynamic hyperinflation and exercise capacity in patients with bronchial asthma." European Respiratory Journal 24.3 (2004): 378-384. Web. 13 June. 2021.

  13. Koutsoukou, A.

    1. Kosmas, E.N. et al "Exercise-induced flow limitation, dynamic hyperinflation and exercise capacity in patients with bronchial asthma." European Respiratory Journal 24.3 (2004): 378-384. Web. 13 June. 2021.

  14. Kwek, S-K.

    1. Ong, K-C. et al "Pulmonary function and exercise capacity in survivors of severe acute respiratory syndrome." European Respiratory Journal 24.3 (2004): 436-442. Web. 13 June. 2021.

L

  1. Lanini, B.

    1. Romagnoli, I. et al "Chest wall kinematics and respiratory muscle action in ankylosing spondylitis patients." European Respiratory Journal 24.3 (2004): 453-460. Web. 13 June. 2021.

  2. Lantuejoul, S.

    1. Lantuejoul, S. et al "Adenocarcinoma of the lung mimicking inflammatory lung disease with honeycombing." European Respiratory Journal 24.3 (2004): 502-505. Web. 13 June. 2021.

  3. Lee, L.S-U.

    1. Ong, K-C. et al "Pulmonary function and exercise capacity in survivors of severe acute respiratory syndrome." European Respiratory Journal 24.3 (2004): 436-442. Web. 13 June. 2021.

  4. Leow, M.K-S.

    1. Ong, K-C. et al "Pulmonary function and exercise capacity in survivors of severe acute respiratory syndrome." European Respiratory Journal 24.3 (2004): 436-442. Web. 13 June. 2021.

  5. Lesman-Leegte, I.G.A.T.

    1. Willemse, B.W.M. et al "Smoking cessation improves both direct and indirect airway hyperresponsiveness in COPD." European Respiratory Journal 24.3 (2004): 391-396. Web. 13 June. 2021.

  6. Liapakis, I.E.

    1. Liapakis, I.E. et al "Penetration of newer quinolones in the empyema fluid." European Respiratory Journal 24.3 (2004): 466-470. Web. 13 June. 2021.

  7. Light, R.W.

    1. Liapakis, I.E. et al "Penetration of newer quinolones in the empyema fluid." European Respiratory Journal 24.3 (2004): 466-470. Web. 13 June. 2021.

  8. Liles, W.C.

    1. Hallstrand, T.S. et al "Inhaled IFN-γ for persistent nontuberculous mycobacterial pulmonary disease due to functional IFN-γ deficiency." European Respiratory Journal 24.3 (2004): 367-370. Web. 13 June. 2021.

  9. Low, S-Y.

    1. Low, S-Y., A. Hsu, and P. Eng. "Interventional bronchoscopy for tuberculous tracheobronchial stenosis." European Respiratory Journal 24.3 (2004): 345-347. Web. 13 June. 2021.

M

  1. Maher, D.

    1. de Colombani, P. et al "European framework to decrease the burden of TB/HIV." European Respiratory Journal 24.3 (2004): 493-501. Web. 13 June. 2021.

  2. Malagari, K.

    1. Kapotsis, G.E. et al "A young male with chest pain, cough and fever." European Respiratory Journal 24.3 (2004): 506-509. Web. 13 June. 2021.

  3. Manes, A.

    1. Humbert, M. et al "Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2." European Respiratory Journal 24.3 (2004): 353-359. Web. 13 June. 2021.

  4. Martínez-Martínez, Á.

    1. Quintana-Gallego, E. et al "Home respiratory polygraphy for diagnosis of sleep-disordered breathing in heart failure." European Respiratory Journal 24.3 (2004): 443-448. Web. 13 June. 2021.

  5. Masoli, M.

    1. Masoli, M. et al " From the authors: ." European Respiratory Journal 24.3 (2004): 513-514. Web. 13 June. 2021.

  6. Maygarden, S.J.

    1. Barker, P.M. et al "Primary pulmonary lymphangiectasia in infancy and childhood." European Respiratory Journal 24.3 (2004): 413-419. Web. 13 June. 2021.

  7. McConnell, A.K.

    1. McConnell, A.K., P. Weiner, and L.M. Romer. "Inspiratory muscle training as a tool for the management of patients with COPD." European Respiratory Journal 24.3 (2004): 510-511. Web. 13 June. 2021.

  8. McElroy, J.J.

    1. Roberts, K.E. et al "BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease." European Respiratory Journal 24.3 (2004): 371-374. Web. 13 June. 2021.

  9. McNicholas, W.T.

    1. McNicholas, W.T.. "Controlling passive smoking through legislation in Ireland: an attack on civil liberty or good public health policy?." European Respiratory Journal 24.3 (2004): 337-338. Web. 13 June. 2021.

  10. Milic-Emili, J.

    1. Kosmas, E.N. et al "Exercise-induced flow limitation, dynamic hyperinflation and exercise capacity in patients with bronchial asthma." European Respiratory Journal 24.3 (2004): 378-384. Web. 13 June. 2021.

  11. Morice, A.H.

    1. Morice, A.H., and . "The diagnosis and management of chronic cough." European Respiratory Journal 24.3 (2004): 481-492. Web. 13 June. 2021.

  12. Morse, J.H.

    1. Roberts, K.E. et al "BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease." European Respiratory Journal 24.3 (2004): 371-374. Web. 13 June. 2021.

  13. Moxham, J.

    1. Hart, N., J. Moxham, and M.I. Polkey. " From the authors: ." European Respiratory Journal 24.3 (2004): 511. Web. 13 June. 2021.

  14. Müller, K.M.

    1. Brasch, F. et al "Surfactant proteins in pulmonary alveolar proteinosis in adults." European Respiratory Journal 24.3 (2004): 426-435. Web. 13 June. 2021.

N

  1. Nanas, S.

    1. Vogiatzis, I. et al "Dynamic hyperinflation and tolerance to interval exercise in patients with advanced COPD." European Respiratory Journal 24.3 (2004): 385-390. Web. 13 June. 2021.

  2. Ng, A.W-K.

    1. Ong, K-C. et al "Pulmonary function and exercise capacity in survivors of severe acute respiratory syndrome." European Respiratory Journal 24.3 (2004): 436-442. Web. 13 June. 2021.

  3. Nillson, T.

    1. Bergdahl, I. et al " From the authors: ." European Respiratory Journal 24.3 (2004): 512. Web. 13 June. 2021.

O

  1. Ochs, H.D.

    1. Hallstrand, T.S. et al "Inhaled IFN-γ for persistent nontuberculous mycobacterial pulmonary disease due to functional IFN-γ deficiency." European Respiratory Journal 24.3 (2004): 367-370. Web. 13 June. 2021.

  2. Ochs, M.

    1. Brasch, F. et al "Surfactant proteins in pulmonary alveolar proteinosis in adults." European Respiratory Journal 24.3 (2004): 426-435. Web. 13 June. 2021.

  3. Ong, K-C.

    1. Ong, K-C. et al "Pulmonary function and exercise capacity in survivors of severe acute respiratory syndrome." European Respiratory Journal 24.3 (2004): 436-442. Web. 13 June. 2021.

P

  1. Papazahou, O.

    1. Vogiatzis, I. et al "Dynamic hyperinflation and tolerance to interval exercise in patients with advanced COPD." European Respiratory Journal 24.3 (2004): 385-390. Web. 13 June. 2021.

  2. Papiris, S.A.

    1. Kapotsis, G.E. et al "A young male with chest pain, cough and fever." European Respiratory Journal 24.3 (2004): 506-509. Web. 13 June. 2021.

  3. Pino, J.M.

    1. García-Río, F. et al "Spirometric reference equations for European females and males aged 65–85 yrs." European Respiratory Journal 24.3 (2004): 397-405. Web. 13 June. 2021.

  4. Pitiakoudis, M.S.

    1. Liapakis, I.E. et al "Penetration of newer quinolones in the empyema fluid." European Respiratory Journal 24.3 (2004): 466-470. Web. 13 June. 2021.

  5. Polkey, M.I.

    1. Hart, N., J. Moxham, and M.I. Polkey. " From the authors: ." European Respiratory Journal 24.3 (2004): 511. Web. 13 June. 2021.

  6. Polo-Padillo, J.

    1. Quintana-Gallego, E. et al "Home respiratory polygraphy for diagnosis of sleep-disordered breathing in heart failure." European Respiratory Journal 24.3 (2004): 443-448. Web. 13 June. 2021.

  7. Polychronaki, A.

    1. Kosmas, E.N. et al "Exercise-induced flow limitation, dynamic hyperinflation and exercise capacity in patients with bronchial asthma." European Respiratory Journal 24.3 (2004): 378-384. Web. 13 June. 2021.

  8. Postma, D.S.

    1. Willemse, B.W.M. et al "Smoking cessation improves both direct and indirect airway hyperresponsiveness in COPD." European Respiratory Journal 24.3 (2004): 391-396. Web. 13 June. 2021.
    2. Visser, M.J. et al "Side-effects of fluticasone in asthmatic children: no effects after dose reduction." European Respiratory Journal 24.3 (2004): 420-425. Web. 13 June. 2021.

Q

  1. Quintana-Gallego, E.

    1. Quintana-Gallego, E. et al "Home respiratory polygraphy for diagnosis of sleep-disordered breathing in heart failure." European Respiratory Journal 24.3 (2004): 443-448. Web. 13 June. 2021.

R

  1. Ramsay, C.

    1. Elston, W.J. et al "Safety of research bronchoscopy, biopsy and bronchoalveolar lavage in asthma." European Respiratory Journal 24.3 (2004): 375-377. Web. 13 June. 2021.

  2. Retsou, S.

    1. Kosmas, E.N. et al "Exercise-induced flow limitation, dynamic hyperinflation and exercise capacity in patients with bronchial asthma." European Respiratory Journal 24.3 (2004): 378-384. Web. 13 June. 2021.

  3. Robbins, I.M.

    1. Humbert, M. et al "Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2." European Respiratory Journal 24.3 (2004): 353-359. Web. 13 June. 2021.

  4. Roberts, K.E.

    1. Roberts, K.E. et al "BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease." European Respiratory Journal 24.3 (2004): 371-374. Web. 13 June. 2021.

  5. Robinson, P.

    1. Griffiths, A.L. et al "Cystic fibrosis patients and families support cross-infection measures." European Respiratory Journal 24.3 (2004): 449-452. Web. 13 June. 2021.

  6. Rodero Baños, A.

    1. Escobar-Sacristán, J.A. et al "Endobronchial brachytherapy in the treatment of malignant lung tumours." European Respiratory Journal 24.3 (2004): 348-352. Web. 13 June. 2021.

  7. Romagnoli, I.

    1. Romagnoli, I. et al "Chest wall kinematics and respiratory muscle action in ankylosing spondylitis patients." European Respiratory Journal 24.3 (2004): 453-460. Web. 13 June. 2021.

  8. Romer, L.M.

    1. McConnell, A.K., P. Weiner, and L.M. Romer. "Inspiratory muscle training as a tool for the management of patients with COPD." European Respiratory Journal 24.3 (2004): 510-511. Web. 13 June. 2021.

  9. Roussos, Ch.

    1. Kosmas, E.N. et al "Exercise-induced flow limitation, dynamic hyperinflation and exercise capacity in patients with bronchial asthma." European Respiratory Journal 24.3 (2004): 378-384. Web. 13 June. 2021.
    2. Vogiatzis, I. et al "Dynamic hyperinflation and tolerance to interval exercise in patients with advanced COPD." European Respiratory Journal 24.3 (2004): 385-390. Web. 13 June. 2021.
    3. Kapotsis, G.E. et al "A young male with chest pain, cough and fever." European Respiratory Journal 24.3 (2004): 506-509. Web. 13 June. 2021.

  10. Rubin, L.J.

    1. Humbert, M. et al "Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2." European Respiratory Journal 24.3 (2004): 353-359. Web. 13 June. 2021.

  11. Rutgers, B.

    1. Willemse, B.W.M. et al "Smoking cessation improves both direct and indirect airway hyperresponsiveness in COPD." European Respiratory Journal 24.3 (2004): 391-396. Web. 13 June. 2021.

S

  1. Saez Valls, R.

    1. Escobar-Sacristán, J.A. et al "Endobronchial brachytherapy in the treatment of malignant lung tumours." European Respiratory Journal 24.3 (2004): 348-352. Web. 13 June. 2021.

  2. Sánchez-Armengol, Á.

    1. Quintana-Gallego, E. et al "Home respiratory polygraphy for diagnosis of sleep-disordered breathing in heart failure." European Respiratory Journal 24.3 (2004): 443-448. Web. 13 June. 2021.

  3. Scano, G.

    1. Romagnoli, I. et al "Chest wall kinematics and respiratory muscle action in ankylosing spondylitis patients." European Respiratory Journal 24.3 (2004): 453-460. Web. 13 June. 2021.

  4. Schoch, O.D.

    1. Brasch, F. et al "Surfactant proteins in pulmonary alveolar proteinosis in adults." European Respiratory Journal 24.3 (2004): 426-435. Web. 13 June. 2021.

  5. Simonneau, G.

    1. Humbert, M. et al "Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2." European Respiratory Journal 24.3 (2004): 353-359. Web. 13 June. 2021.

  6. Simopoulos, C.E.

    1. Liapakis, I.E. et al "Penetration of newer quinolones in the empyema fluid." European Respiratory Journal 24.3 (2004): 466-470. Web. 13 June. 2021.

  7. Strachan, D.P.

    1. Weiland, S.K. et al "Phase II of the International Study of Asthma and Allergies in Childhood (ISAAC II): rationale and methods." European Respiratory Journal 24.3 (2004): 406-412. Web. 13 June. 2021.

T

  1. ten Hacken, N.H.T.

    1. Willemse, B.W.M. et al "Smoking cessation improves both direct and indirect airway hyperresponsiveness in COPD." European Respiratory Journal 24.3 (2004): 391-396. Web. 13 June. 2021.

  2. Timens, W.

    1. Willemse, B.W.M. et al "Smoking cessation improves both direct and indirect airway hyperresponsiveness in COPD." European Respiratory Journal 24.3 (2004): 391-396. Web. 13 June. 2021.

  3. Torén, K.

    1. Bergdahl, I. et al " From the authors: ." European Respiratory Journal 24.3 (2004): 512. Web. 13 June. 2021.

  4. Tsatsakis, A.M.

    1. Liapakis, I.E. et al "Penetration of newer quinolones in the empyema fluid." European Respiratory Journal 24.3 (2004): 466-470. Web. 13 June. 2021.

  5. Tzatzarakis, M.N.

    1. Liapakis, I.E. et al "Penetration of newer quinolones in the empyema fluid." European Respiratory Journal 24.3 (2004): 466-470. Web. 13 June. 2021.

V

  1. Vamvouka, C.

    1. Kapotsis, G.E. et al "A young male with chest pain, cough and fever." European Respiratory Journal 24.3 (2004): 506-509. Web. 13 June. 2021.

  2. van der Veer, E.

    1. Visser, M.J. et al "Side-effects of fluticasone in asthmatic children: no effects after dose reduction." European Respiratory Journal 24.3 (2004): 420-425. Web. 13 June. 2021.

  3. Villa-Gil, M.

    1. Quintana-Gallego, E. et al "Home respiratory polygraphy for diagnosis of sleep-disordered breathing in heart failure." European Respiratory Journal 24.3 (2004): 443-448. Web. 13 June. 2021.

  4. Villamor, J.

    1. García-Río, F. et al "Spirometric reference equations for European females and males aged 65–85 yrs." European Respiratory Journal 24.3 (2004): 397-405. Web. 13 June. 2021.

  5. Visser, M.J.

    1. Visser, M.J. et al "Side-effects of fluticasone in asthmatic children: no effects after dose reduction." European Respiratory Journal 24.3 (2004): 420-425. Web. 13 June. 2021.

  6. Vogiatzis, I.

    1. Vogiatzis, I. et al "Dynamic hyperinflation and tolerance to interval exercise in patients with advanced COPD." European Respiratory Journal 24.3 (2004): 385-390. Web. 13 June. 2021.

  7. von Mutius, E.

    1. Weiland, S.K. et al "Phase II of the International Study of Asthma and Allergies in Childhood (ISAAC II): rationale and methods." European Respiratory Journal 24.3 (2004): 406-412. Web. 13 June. 2021.

W

  1. Weatherall, M.

    1. Masoli, M. et al " From the authors: ." European Respiratory Journal 24.3 (2004): 513-514. Web. 13 June. 2021.

  2. Weiland, S.K.

    1. Weiland, S.K. et al "Phase II of the International Study of Asthma and Allergies in Childhood (ISAAC II): rationale and methods." European Respiratory Journal 24.3 (2004): 406-412. Web. 13 June. 2021.

  3. Weiner, P.

    1. McConnell, A.K., P. Weiner, and L.M. Romer. "Inspiratory muscle training as a tool for the management of patients with COPD." European Respiratory Journal 24.3 (2004): 510-511. Web. 13 June. 2021.

  4. Whittaker, A.J.

    1. Elston, W.J. et al "Safety of research bronchoscopy, biopsy and bronchoalveolar lavage in asthma." European Respiratory Journal 24.3 (2004): 375-377. Web. 13 June. 2021.

  5. Widlitz, A.

    1. Roberts, K.E. et al "BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease." European Respiratory Journal 24.3 (2004): 371-374. Web. 13 June. 2021.

  6. Wild, M.R.

    1. Wild, M.R. et al "Can psychological factors help us to determine adherence to CPAP? A prospective study." European Respiratory Journal 24.3 (2004): 461-465. Web. 13 June. 2021.

  7. Willemse, B.W.M.

    1. Willemse, B.W.M. et al "Smoking cessation improves both direct and indirect airway hyperresponsiveness in COPD." European Respiratory Journal 24.3 (2004): 391-396. Web. 13 June. 2021.

  8. Wong, W.P.K.

    1. Roberts, K.E. et al "BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease." European Respiratory Journal 24.3 (2004): 371-374. Web. 13 June. 2021.

Y

  1. Yang, Y.

    1. Yang, Y. et al "Regulation of interleukin-1β and interleukin-1β inhibitor release by human airway epithelial cells." European Respiratory Journal 24.3 (2004): 360-366. Web. 13 June. 2021.

  2. Yen, E.

    1. Roberts, K.E. et al "BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease." European Respiratory Journal 24.3 (2004): 371-374. Web. 13 June. 2021.

  3. Ypsilantis, P.

    1. Liapakis, I.E. et al "Penetration of newer quinolones in the empyema fluid." European Respiratory Journal 24.3 (2004): 466-470. Web. 13 June. 2021.

Z

  1. Zaleskis, R.

    1. de Colombani, P. et al "European framework to decrease the burden of TB/HIV." European Respiratory Journal 24.3 (2004): 493-501. Web. 13 June. 2021.

  2. Zhu, Q.

    1. Hallstrand, T.S. et al "Inhaled IFN-γ for persistent nontuberculous mycobacterial pulmonary disease due to functional IFN-γ deficiency." European Respiratory Journal 24.3 (2004): 367-370. Web. 13 June. 2021.
Back to top

Search Within This Issue

Jump to

Manage Table of content Alerts